Actuate Therapeutics (ACTU) Selling, General & Administrative (2023 - 2026)
Actuate Therapeutics (ACTU) reported Selling, General & Administrative of $2.84 million for Q2 2026, down 11.4% from $3.2 million a year earlier.
Powered by 
Analysis
Actuate Therapeutics (ACTU) Selling, General & Administrative (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Actuate Therapeutics' Selling, General & Administrative came in at $11.9 million, up 9.6% year-over-year; for FY2025, it was $12.2 million, up 88.2% from FY2024.
- By year, Selling, General & Administrative came in at $6.48 million in FY2024 (+98.6%) and $3.27 million in FY2023.
- Five-year quarterly Selling, General & Administrative spans a low of $714,167 in Q3 2023 and a high of $3.29 million in Q3 2025.
- Year over year, Selling, General & Administrative gained in five of the last seven quarters, with growth averaging 121.5%.
- The high point for year-over-year Selling, General & Administrative in five years was Q1 2025 (growth of 244.6%); the low point was Q2 2026 (a decline of 11.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Actuate Therapeutics | 7.20 Mn | -35.44 Mn | - | 2.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.84 Mn |
| Mar 31, 2026 | 3.14 Mn |
| Dec 31, 2025 | 2.56 Mn |
| Sep 30, 2025 | 3.29 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 3.15 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 912,824.00 |
| Dec 31, 2023 | 969,354.00 |
| Sep 30, 2023 | 714,167.00 |
| Jun 30, 2023 | 807,177.00 |
API Access
Actuate Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ACTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ACTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ACTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();